PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-232

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 345 Posts.
    lightbulb Created with Sketch. 93
    Makes you wonder does it?

    We are left to ponder, is Paul acting/behaving based off non disclosed information that is confidential in the “deal” process and after the regulatory amendments and DMOAD label clarity, we will land multiple regional binding deals…. and all will be forgiven…… Or is he misbehaving - badly!

    @bobsee @Denial what are you thoughts?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.